RXO, Inc.RXONYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
3Y CAGR-54.2%
5Y CAGR-36.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-54.2%/yr
Annual compound
5Y CAGR
-36.2%/yr
Recent deceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM0.42%-83.7%
20242.57%-24.6%
20233.41%-21.7%
20224.36%-24.9%
20215.80%+46.4%
20203.96%-25.0%
20195.28%-